510(k) K230104
K230104 is an FDA 510(k) premarket notification submitted by Anthogyr for the device "Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL". The FDA issued a decision of Substantially Equivalent on Oct 16, 2023. The device falls under product code DZE (Implant, Endosseous, Root-Form), a Class II device regulated under 21 CFR 872.3640. Anthogyr has 15 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 16, 2023
- Date Received
- Jan 13, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Implant, Endosseous, Root-Form
- Device Class
- Class II
- Regulation Number
- 872.3640
- Review Panel
- DE
- Submission Type
- 510(k)
Need the full FDA record for Anthogyr? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.